(PRWEB) April 24, 2015
On Friday, April 24, from 8:00 – 10 a.m., Greenberg Traurig, LLP’s Boston office will sponsor and host the breakfast program, "Trends in the Israeli Life Sciences Arena," featuring guest speaker Elka Nir and a case study of Israeli medical device company Laryngoport Ltd. The New England-Israel Business Council (NEIBC), an organization focused on increasing economic development in Israel and New England by fostering cooperation, investment opportunities, and business relationships, organized the event. Greenberg Traurig shareholders and patent attorneys David J. Dykeman and Roman Fayerberg will serve as hosts and discussion moderators.
Dykeman is a registered patent attorney, co-chair of Greenberg Traurig’s Global Life Sciences & Medical Technology Group, and co-chair of the firm’s Intellectual Property (IP) Group in Boston. With over 18 years of experience in patents, intellectual property, and licensing, Dykeman focuses his practice on securing strategic worldwide intellectual property protection and related business strategy for high-tech clients, with particular expertise in medical devices, life sciences, biotechnology, and health care IT. Dykeman is the founding co-chair of the American Bar Association’s (ABA) Medical Devices Committee, and serves on the Editorial Advisory Board of Medical Device + Diagnostic Industry (MD+DI) Magazine.
Fayerberg is a registered patent attorney and shareholder in the firm’s Intellectual Property (IP) Group in Boston. He focuses his practice on the development and management of strategic patent portfolios and counseling clients on patent issues, primarily in technologies related to life sciences. He also advises clients in connection with intellectual property due diligence investigations for venture capital investment, mergers and acquisitions, and licensing opportunities. His patent practice builds on seven years of experience gained as a research and development engineer at C.R. Bard and Boston Scientific Corporation.
About Greenberg Traurig’s Israel Practice
Greenberg Traurig’s Israel Practice offers clients a global network of professionals with the legal experience, business alliances, technical knowledge, political relations, language capabilities and cultural understanding to deliver innovative legal strategies for Israeli businesses and individuals. The Tel Aviv office serves as a gateway for Israeli businesses and entrepreneurs doing business around the world, as well as companies seeking opportunities within Israel. Greenberg Traurig’s Israel Practice provides a wide range of legal services to clients in Israel who need U.S. and UK counsel, as well as legal services from other international jurisdictions. (Attorneys in the office do not practice Israeli law.) As a result of the firm’s experience advising multinationals with locations in Israel, Europe, the United States, Latin America and Asia, the group’s attorneys are familiar with a variety of legal frameworks and work with clients to bridge the legal and regulatory gaps on cross-border deals. Greenberg Traurig also has a strong track record of matching Israeli companies with strategic partners, potential joint ventures and other business-to-business connections.
About Greenberg Traurig’s Life Sciences & Medical Technology Group
Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from start-ups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.
About Greenberg Traurig, LLP
Greenberg Traurig, LLP is an international, multi-practice law firm with approximately 1800 attorneys serving clients from 37 offices in the United States, Latin America, Europe, Asia, and the Middle East. The firm is among the “Power Elite” in the 2014 BTI Client Relationship Scorecard report, which assesses the nature and strength of law firms' client relationships. For additional information, please visit http://www.gtlaw.com.